Arbutus Biopharma Corp Annual Operating Margin in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Arbutus Biopharma Corp quarterly/annual Operating Margin history and growth rate from 2011 to 2023.
  • Arbutus Biopharma Corp Operating Margin for the quarter ending June 30, 2024 was -827 %, a 156% decline year-over-year.
  • Arbutus Biopharma Corp annual Operating Margin for 2023 was -431 %, a 157% decline from 2022.
  • Arbutus Biopharma Corp annual Operating Margin for 2022 was -168 %, a 74.9% increase from 2021.
  • Arbutus Biopharma Corp annual Operating Margin for 2021 was -669 %, a 20% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -431 -263 -157% Jan 1, 2023 Dec 31, 2023
2022 -168 +501 +74.9% Jan 1, 2022 Dec 31, 2022
2021 -669 +167 +20% Jan 1, 2021 Dec 31, 2021
2020 -836 +1.56K +65.1% Jan 1, 2020 Dec 31, 2020
2019 -2.39K -884 -58.5% Jan 1, 2019 Dec 31, 2019
2018 -1.51K -473 -45.7% Jan 1, 2018 Dec 31, 2018
2017 -1.04K +31.9K +96.9% Jan 1, 2017 Dec 31, 2017
2016 -33K -32.5K -7286% Jan 1, 2016 Dec 31, 2016
2015 -446 -223 -99.7% Jan 1, 2015 Dec 31, 2015
2014 -224 -145 -185% Jan 1, 2014 Dec 31, 2014
2013 -78.6 +13.2 +14.4% Jan 1, 2013 Dec 31, 2013
2012 -91.8 -28.2 -44.3% Jan 1, 2012 Dec 31, 2012
2011 -63.6 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.